Bacterial cell wall and cytoplasmic membrane anionic components Overview
Bacterial cell wall and cytoplasmic membrane anionic components comprise a diverse group of negatively charged molecules essential for bacterial viability and structural integrity. In Gram-negative bacteria, the primary anionic component is lipopolysaccharide (LPS) located in the outer membrane, while Gram-positive bacteria utilize wall teichoic acids (WTA) and lipoteichoic acids (LTA) to maintain a negative surface charge. Additionally, both groups contain anionic phospholipids, such as phosphatidylglycerol and cardiolipin, within their cytoplasmic membranes that contribute to the overall electronegativity of the cell envelope. These components play critical roles in ion homeostasis, particularly the sequestration of divalent cations like magnesium, and serve as protective barriers against environmental threats. Therapeutically, these anionic structures are the primary targets for several classes of rapidly bactericidal antibiotics, including polymyxins and lipopeptides like daptomycin. These drugs typically possess cationic regions that are electrostatically attracted to the anionic bacterial surface, allowing them to bypass host cells, which generally have zwitterionic outer membranes. Upon binding, these agents disrupt membrane potential or physical integrity, leading to rapid cell death. However, the clinical use of such drugs is often limited by toxicity concerns, such as nephrotoxicity, and the potential for bacteria to evolve resistance by modifying their surface charge to repel cationic molecules.
Mechanism of Action
Drugs target these components through electrostatic attraction between their cationic moieties and the anionic bacterial surface. This interaction leads to membrane insertion, depolarization, pore formation, and physical disruption of the cell envelope, ultimately causing leakage of intracellular contents and cell death. Some agents also inhibit cell wall synthesis by sequestering lipid-linked precursors associated with these anionic structures.
Biological Functions
Disease Associations
Safety Considerations
- Nephrotoxicity
- Neurotoxicity
- Myopathy
- Systemic inflammatory response syndrome (SIRS) due to rapid release of immunostimulatory components like LPS or LTA
- Development of resistance via surface charge modification (e.g., mcr-1 mediated lipid A modification)
Interacting Drugs
Associated Biomarkers
| Biomarker |
|---|
| Bacterial load |
| C-reactive protein (CRP) |
| Procalcitonin |
| Endotoxin (LPS) levels |
| Creatine phosphokinase (CPK) for daptomycin monitoring |
Gosset